Chester County News and Community Website
COLMAR, PA — Dorman Products, Inc. (NASDAQ: DORM), a leading supplier in the automotive aftermarket sector, announced the release of hundreds of new vehicle components and assemblies this week. The …
Dorman Products Unveils Hundreds of New Auto Parts, Bolstering Aftermarket Offerings Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) has unveiled its latest innovation, a 25 MBd high-speed optocoupler designed to streamline integration into digital systems. The newly released VOIH72A, distinguished …
Vishay Introduces Advanced Optocoupler for Industrial Applications, Boosting Digital Integration and Efficiency Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced that Humana, a major U.S. health insurer, has updated its coverage policy to include adolescents aged 15-21 in response to …
Humana Pioneers Coverage Expansion for Adolescent Depression Treatment Following FDA Clearance Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. This collaboration marks a critical step …
Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial Read More
CHESTERBROOK, PA — Trevena Inc. (Nasdaq: TRVN), a biopharmaceutical company, spotlighted its first-quarter achievements and financial standing, underscoring advancements in its novel treatment for chronic pain and epilepsy and strategic …
Trevena Reports Progress in Pain and Epilepsy Treatment Development, Amid Financial Adjustments Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) this week unveiled promising updates on its clinical trials and financial standing for the first quarter ending March 31, 2024. The company’s …
Cabaletta Bio Reports Promising Advances in Autoimmune Disease Trials, Looks to Future Innovations Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on innovative therapies, announced the completion of dosing in the second cohort of its groundbreaking GARDian clinical trial for …
Ocugen Advances with Phase 1/2 Trial for Stargardt Disease Treatment Read More
MALVERN, PA — Rajant Corporation, based in Chester County, Pennsylvania, with significant operations in Morehead, Kentucky, has once again been recognized for its exceptional workplace culture and policies. For the …
Rajant Corporation Secures Prestigious Workplace Awards for Fourth Consecutive Year Read More
PHILADELPHIA, PA — The Wistar Institute announced a significant boost for its Biomedical Technician Training (BTT) Pre-apprenticeship Program, receiving a $649,971 grant from the National Science Foundation (NSF). This funding …
Wistar Institute Secures NSF Grant to Expand Biomedical Technician Training Program Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel cancer treatments, reported notable advancements in its first-quarter financial results and clinical trials, including receiving …
Aprea Therapeutics Announces Positive First Quarter Developments and FDA Clearance for Cancer Drug Trials Read More